Filings

7 documents · 34 matches

1. GANX Gain Therapeutics, Inc. 10-K 2026-03-26

   Item 1A. Risk Factors

   tariffs, non-tariff barriers, or export controls. Any of these risks, ensuing retaliation, or the further deterioration of trade relations
   14 matches in this document Show context Copy citation

2. GANX Gain Therapeutics, Inc. 10-Q 2025-05-14

   Item 1A. Risk Factors.

   tariffs will result in increased research and development expenses, including with respect to increased costs associated with APIs. In addition
   7 matches in this document Show context Copy citation

3. GANX Gain Therapeutics, Inc. 10-Q 2026-11-10

   Item 6.

   tariffs, import quotas or other trade restrictions or measures taken by the United States and other countries, including changes in U.S. trade
   3 matches in this document Show context Copy citation

4. GANX Gain Therapeutics, Inc. 10-Q 2026-08-11

   Item 6.

   tariffs, import quotas or other trade restrictions or measures taken by the United States and other countries, including changes in U.S. trade
   3 matches in this document Show context Copy citation

5. GANX Gain Therapeutics, Inc. 10-Q 2026-05-11

   Item 6.

   tariffs, import quotas or other trade restrictions or measures taken by the United States and other countries, including changes in U.S. trade
   3 matches in this document Show context Copy citation

6. GANX Gain Therapeutics, Inc. 10-Q 2025-11-12

   Item 6.

   ● the impacts of changes to international trade policy, including tariff and customs regulations; and
   2 matches in this document Show context Copy citation

7. GANX Gain Therapeutics, Inc. 10-Q 2025-08-12

   Item 6.

   ● the impacts of changes to international trade policy, including tariff and customs regulations; and
   2 matches in this document Show context Copy citation